<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR38">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Palumbo</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Bringhen</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Bertola</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Cavallo</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Falco</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Massaia</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Bruno</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Rus</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Barbui</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Caravita</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Musto</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Pescosta</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Rossini</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Vignetti</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Boccadoro</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))</article-title>
  <source>Leukemia</source>
  <year>2004</year>
  <volume>18</volume>
  <issue>1</issue>
  <fpage>133</fpage>
  <lpage>138</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.leu.2403196</pub-id>
  <pub-id pub-id-type="pmid">14586481</pub-id>
 </element-citation>
</ref>
